Abstract Purpose: To determine the toxicity, anti-inflammatory and analgesic properties of Deverra scoparia Coss. & Dur. and the phenolic compounds involved
INTRODUCTION
For centuries, medicinal plants have been widely used for the treatment of various ailments 1. Indeed, about 80 % of the people from developing countries depend on traditional remedies for their primary health care 2. The use of alternative medicines derived from natural sources has also spread to the industrialized nations. Indeed, a variety of herbal plants has been extensively used for the extraction of pure compounds used in the development of new drugs 3. Pain is a disabling discomfort associated with many medical conditions. One of the most important therapeutic priorities in handling pain involves pain control 4. Synthetic drugs like non-steroidal anti-inflammatory drugs (NSAIDs), opioids and corticosteroids are the major clinically-used drugs for treating and reducing pain. However, their long term usage may induce toxic effects such as ulcers of gastrointestines, nausea, hemorrhage, and kidney disorders 5. In this regard, there is a need to search for medicinal plant-derived bioactive compounds with little or no side effects, for use as alternative analgesic and antiinflammatory agents 6.
Deverra scoparia Coss. & Dur., a medicinal plant belonging to the Apiaceae family, is an endemic species of North African origin. Based on ethnobotanical evidence reported in the literature 7-9, the aerial parts of Deverra scoparia Coss. & Dur. have very important pharmacological properties 7,8. This plant is used by the Algerian local population (Tergui) to treat several infectious diseases, digestive disorders and to calm abdominal pain 7. However, extensive review of extant literature has revealed that no pharmacological studies have been so far been conducted on the acute toxicity, antiinflammatory activity and the analgesic potential of Deverra scoparia Coss. & Dur. The present study was carried out to determine the antiinflammatory and analgesic properties of Deverra scoparia Coss. & Dur. and the identity of the active compounds responsible for these activities.
EXPERIMENTAL Plant material
Deverra scoparia Coss. & Dur. was collected in March, 2016 from Hoggar area located in Tamanrasset region (South of Algeria), and was identified by a taxonomist, Pr. Saida Ouafi, of Department of Biological Sciences of University of Sciences and Technology Houari Boumediene. A voucher specimen (number 38) was deposited at the herbarium of the National Institute of Agronomy, Algeria (INA). The aerial parts of the plant were shade-dried at room temperature (24 ± 2 °C) and preserved in paper bags, in order to avoid fungal contamination. The plant material (1Kg) was chopped into small pieces with a knife and then ground to a fine powder in an electric blender.
Preparation of aqueous extract
An aqueous extract of Deverra scoparia Coss. & Dur. was prepared using infusion method. The powdered plant material was macerated, with continuous stirring in boiling distilled water for a few minutes, and the resultant infusion was filtered through Whatman no. 1 filter paper.
Experimental animals
Healthy male and female Wistar albino rats (mean weight = 200 ± 20 g) and healthy male and female albino mice, Mus musculus (mean weight = 20 ± 5 g) were obtained from Animal Laboratory of Biotic Unit (Saidal, Algeria). The animals were fed pellet diet from the National Office of Animal Feed (Bejaia-Algeria). The pellet feed and drinking water were provided ad libitum. The animals were also kept and maintained under standard laboratory conditions at a temperature of 24 ± 2˚C, 12h light/dark cycle, and relative humidity in the range of 50 to 55 %. All experimental procedures were approved by the University Animal Experimentation Ethics Committee (approval ref no. 162/2011/8), and followed the recommendation of the care and use guide for laboratory animals 10.
Acute oral toxicity test
The acute oral toxicity test of the aqueous infusion extract of Deverra scoparia Coss. & Dur. was determined as per OECD-423 guidelines, but with slight modifications 11. Sixty albino mice were divided into six equal groups (n=10; 5 males and 5 females), one of which was used as a control. The mice were fasted for 12 h prior to the experiment but were allowed free access to drinking water. Different doses of the aqueous extract (2, 4, 8, 12 and 16 g/kg) were administered, each in a volume of 0.5 mL, while mice in the control group received 0.5 mL of sterile saline water (0.9 % NaCl). Close observations of behavioral changes in the mice was conducted up to 4 h following extract administration, and once every day until the fourteenth day. The behavioral changes of interest were salivation, diarrhea, tremors, ataxia, hyperactivity, lethargy, convulsions, sleep and coma. At the end of the observation period, the animals were anaesthetized, sacrificed and autopsied. The heart, lung, kidney and liver samples were excised and examined for any lesions in the treated groups, relative to the control group.
Determination of analgesic activity

Acetic acid-induced writhing test
This study was performed using the abdominal writhing method described by Koster et al 12 and modified by Vogel 13. Thirty albino mice of both sexes were randomly divided into five groups each containing six mice. The aqueous infusion extract of Deverra scoparia Coss. & Dur. was administered separately by gastric gavage to three of the mice groups at doses of 250, 500 and 1000 mg/kg per body weight. The negative and positive control groups received sterile saline water (0.9 % NaCl) and Aspirin (500 mg/kg), respectively.
Thirty minutes after oral administration of the aqueous infusion extract and the drug, 0.6 % acetic acid (1 mL/kg) was given intraperitoneally to induce pain which was manifested in abdominal constrictions (writhes). After 5 min, each group of mice was monitored for the number of writhes within 15 min. The percentage of inhibition by plant extract and aspirin against acetic acid-induced abdominal writhing was used to evaluate the degree of analgesia (A) and was calculated for each group using Eq 1. (1) where W e represents the mean value of writhes in treated groups and W t represents the mean value of writhes in control groups.
Formalin test
Formalin test was carried out using the methods of Hunskaar et al 14 and Miranda et al 15.
Rats of both sexes were divided into five groups (six rats per group); three groups were orally treated (separately) with the aqueous infusion extract at doses of 250, 500 and 1000 mg/kg per body weight, Aspirin (500 mg/kg) and sterile saline (0.9% NaCl) were administered orally to the other two groups which served as positive and negative controls, respectively. Thirty minutes after treatment, 50 μL of 2.5% formalin was injected subcutaneously into the dorsal surface of the right hind paw. The time spent in licking the injected paw was recorded by visual observation in the early phase (0 -5 min) and late phase (15 -30 min). The inhibition of licking (L) for both phases was calculated as in Eq 2.
where, D t is the mean value of licking time in the treated groups, and D o is the mean value of licking time in the control groups.
Determination of anti-inflammatory activity
The anti-inflammatory activity of the aqueous infusion extracted of the aerial parts of Deverra scoparia Coss. & Dur. was determined using the procedure previously described by Levy 16. Albino mice were divided into five groups (six animals per group). Group I, (negative control) mice were treated with 0.9% sterile saline, whereas mice in group II (positive control) were treated with diclofenac sodium (500 mg/kg). The remaining groups (III, IV and V) received the aqueous infusion extract at three different concentrations (250, 500 and 1000 mg/kg per body weight, respectively). One hour after the oral administration of all treatments, oedema was induced by injecting carrageenan suspension (0.05 mL, 1 % w/v) into the sub-plantar tissues of the right hind paw of all mice. After 3 h the animals were anesthetized with diethyl ether and sacrificed. The two posterior legs were excised at the tarsal joint and then weighed in an analytical balance.
For each mouse, the percentage oedema was calculated after recording the increase in the weight of the right posterior leg which received the carrageenan suspension, and the weight of the healthy left posterior leg. The percentage of oedema (O %) was calculated by determining the mean weight of both legs for each group, according to Eq 3. (4) where, I (%) is the inhibition percentage, %c o is the % of the control oedema and % to is the % of the test oedema.
HPLC analysis
HPLC analysis was carried out for the identification and quantification of phenolic compounds in the extract using Agilent series 1100 chromatography system coupled with UV Detector and bars of Diodes Surveyor, equipped with quaternary rapid separation pump. Separation was performed on Hypersil BDS-C18 column (250 × 4.6 mm, 5µm). Analysis was carried out injecting 20 μL, while the mobile phase consisted of two solvents: acetic acid (0.2% of acetic acid in water) and acetonitrile in a linear gradient for 30 min at a flow rate of 1.5 mL/min. The mobile phase started with 95 % of acetic acid, and ended with 100 % of acetonitrile.
Statistical analysis
Data are expressed as mean ± standard error of mean (SEM). Statistical analysis was performed using one-way analysis of variance (ANOVA), followed by Tukey's test. Values of p < 0.001 and p < 0.05 were considered statistically significant.
RESULTS
Acute toxicity
The acute toxicity test was carried out in order to determine the toxicity of the aerial parts of Deverra scoparia Coss. & Dur. during the 14 days observation period, no behavioural changes, such as convulsion, hyperactivity, irritability diarrhea or mortalities were observed. The weights of the mice were not affected at any of the administered doses and all the vital organs (kidney, liver, lung and heart) were healthy and normal following necropsy. There were also no signs of cysts, swelling or hamorrhage. The results showed that administration of the different doses of the aqueous infusion extract of Deverra scoparia Coss. & Dur. significantly (p < 0.001) reduced abdominal writhing in mice, when compared with the negative control group. All doses of the aqueous infusion extract showed strong significant analgesic action in the tested animals, by inhibiting the acetic acid-induced writhing dose-dependently, causing 50.84, 61.01 and 71.18 % of inhibitions at 250, 500 and 1000 mg/kg, respectively. In contrast, aspirin (500 mg/kg) produced only 47.45 % writhing inhibition effect (Table 1) .
Analgesic activity
Acetic acid-induced writhing
Formalin test results
The evaluation of the analgesic activity was conducted using the formalin test. The results on Table 2 show that the extract produced significant and dose-dependent percentage inhibition of the number of writhes at the early and late phases, when compared with the control group (p < 0.001). Maximum percentage inhibition was obtained at a dose of 1000mg/Kg (71.42 % in early phase), and (83.58 % in the late phase).
Anti-inflammatory activity
Oral administration of the aqueous infusion extract of aerial parts of Deverra scoparia Coss. & Dur. to mice with carrageenan-induced hind paw oedema produced significant (p < 0.001) anti-inflammatory activity at all doses tested (Error! Reference source not found.). There was a gradual decrease in oedema paw volume from 15.66 % at 250 mg/kg down to 8.68% at a dose of 1000 mg/kg, indicating that the effect of the extract was dose-dependent. Similarly, a significant increase (p < 0.001) in percentage inhibition of carrageenan-associated oedema was produced at 250 (52.22 %), 500 (66.13 %) and 1000 (73.52 %) mg/kg while the reference drug diclofenac sodium exhibited 47.95 % inhibition. 
HPLC chromatograms
Phenolic compounds in the aqueous infusion extract of aerial parts of Deverra scoparia Coss. & Dur. were identified and quantified by HPLC. The profile (Figure 1 ) was detected at 365 nm, the wavelength used for the detection of several flavonoid compounds. The HPLC chromatogram revealed the presence of several compounds, five were identified by comparison with their retention times and UV absorbance of purified external standards. Three flavonoids (luteolin, apigenin and kaempferol), and two phenolic acids (salicylic acid and rosmarinic acid) were identified. The present study shows that the aqueous infusion extract of Deverra scoparia Coss. & Dur. significantly reduced carrageenan-induced paw oedema, when compared to the reference drug, diclofenac sodium (500 mg/Kg). This inhibition of inflammation may be due to the blockage of the synthesis of some mediators such as histamines and prostaglandins by the plant extract 21. In order to reveal the nature of the phytochemical compounds that could be responsible for these biological activities, HPLC analysis was performed. The results showed the presence of three potential bioactive molecules, two of which are phenolic acids, salicylic acid (21.81 mg/g dry weight) and rosmarinic acid (28.44 mg/g dry weight), and one flavonoid aglycone, (apigenin 5.70 mg/g dry weight). These compounds may account for the observed anti-inflammatory and analgesic activities of the extract. Many studies have demonstrated that salicylic acid exerts potential analgesic and anti-inflammatory effect by blocking the enzymes responsible for the production of prostaglandins and thromboxanes 22, 23. Rosmarinic acid reduces inflammation by inhibiting prostaglandins biosynthesis 24, while apigenin inhibits inflammation by suppressing the expression of cycolooxygenase-2 (COX-2), a pro-inflammation enzyme 25.
CONCLUSION
The aqueous extract of Deverra scoparia Coss. & Dur.
possesses analgesic and antiinflammatory properties. These pharmacological properties could be due to the presence of bioactive phenolic compounds such as salicylic and rosmarinic acids as well as apigenin. 
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